Your browser doesn't support javascript.
loading
Personalized Development of Antisense Oligonucleotides for Exon Skipping Restores Type XVII Collagen Expression in Junctional Epidermolysis Bullosa.
Ablinger, Michael; Lettner, Thomas; Friedl, Nicole; Potocki, Hannah; Palmetzhofer, Theresa; Koller, Ulrich; Illmer, Julia; Liemberger, Bernadette; Hainzl, Stefan; Klausegger, Alfred; Reisenberger, Manuela; Lambert, Jo; Van Gele, Mireille; Desmet, Eline; Van Maelsaeke, Els; Wimmer, Monika; Zauner, Roland; Bauer, Johann W; Wally, Verena.
Afiliação
  • Ablinger M; Research Program for Molecular Therapy of Genodermatoses, EB House Austria, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria.
  • Lettner T; Research Program for Molecular Therapy of Genodermatoses, EB House Austria, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria.
  • Friedl N; Research Program for Molecular Therapy of Genodermatoses, EB House Austria, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria.
  • Potocki H; Research Program for Molecular Therapy of Genodermatoses, EB House Austria, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria.
  • Palmetzhofer T; Research Program for Molecular Therapy of Genodermatoses, EB House Austria, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria.
  • Koller U; Research Program for Molecular Therapy of Genodermatoses, EB House Austria, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria.
  • Illmer J; Research Program for Molecular Therapy of Genodermatoses, EB House Austria, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria.
  • Liemberger B; Research Program for Molecular Therapy of Genodermatoses, EB House Austria, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria.
  • Hainzl S; Research Program for Molecular Therapy of Genodermatoses, EB House Austria, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria.
  • Klausegger A; Research Program for Molecular Therapy of Genodermatoses, EB House Austria, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria.
  • Reisenberger M; Research Program for Molecular Therapy of Genodermatoses, EB House Austria, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria.
  • Lambert J; Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria.
  • Van Gele M; Department of Dermatology, Ghent University Hospital, 9000 Ghent, Belgium.
  • Desmet E; Department of Dermatology, Ghent University Hospital, 9000 Ghent, Belgium.
  • Van Maelsaeke E; Department of Dermatology, Ghent University Hospital, 9000 Ghent, Belgium.
  • Wimmer M; Department of Dermatology, Ghent University Hospital, 9000 Ghent, Belgium.
  • Zauner R; Research Program for Molecular Therapy of Genodermatoses, EB House Austria, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria.
  • Bauer JW; Research Program for Molecular Therapy of Genodermatoses, EB House Austria, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria.
  • Wally V; Research Program for Molecular Therapy of Genodermatoses, EB House Austria, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria.
Int J Mol Sci ; 22(7)2021 Mar 24.
Article em En | MEDLINE | ID: mdl-33805154
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Autoantígenos / Splicing de RNA / Epidermólise Bolhosa Juncional / Oligonucleotídeos Antissenso / Colágenos não Fibrilares Limite: Humans Idioma: En Revista: Int J Mol Sci Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Áustria
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Autoantígenos / Splicing de RNA / Epidermólise Bolhosa Juncional / Oligonucleotídeos Antissenso / Colágenos não Fibrilares Limite: Humans Idioma: En Revista: Int J Mol Sci Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Áustria